Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: | Endocrinology | Family Medicine
Search Medical Condition
Diabetes Mellitus Types I and II Clinical Trials
A listing of Diabetes Mellitus Types I and II medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Found (29) clinical trials
Diabetes Mellitus Types I and II
Rapid Medical Research is looking for Type 1 or Type 2 Diabetics to take part in a research study.
Diabetic Neuropathy in Type 1 and 2 Diabetics
Northern California Research is conducting a study for diabetic peripheral neuropathy (DPN). DPN is a type of nerve damage that can occur if you have diabetes. This study is for men and women who are experiencing painful diabetic peripheral neuropathy in both lower extremities (legs). The specific events that result ...
Clinical Protocol MB102230
A Multicenter, Randomized, Double-Blind, Placebo-controlled, Parallel Group, Phase 3 Study to Evaluate the Efficacy and Safety of Dapagliflozin as an Add-on to Insulin Therapy in Subjects with Type 1 Diabetes Mellitus.
LixiLan-G EFC13794
A 26-week open-label study assessing the efficacy and safety of the insulin glargine/lixisenatide fixed ratio combination in adults with Type 2 Diabetes inadequately controlled on GLP-1 receptor agonist and metformin ± pioglitazone.
LPS 14347 Achieve Control Real Life Study Program
A randomized, open-label, parallel group real world pragmatic trial to assess the clinical and health outcomes of Toujeo® compared to commercially available basal insulins for initiation of therapy in insulin naïve patients with uncontrolled type 2 diabetes mellitus.
A long-term 4+ year, double blind placebo controlled study to evaluate the effects of bexagliflozin on hemoglobin A1c in patients with type 2 diabetes and increased risk of cardiovascular adverse events
Patients with type 2 diabetes have increased risk of developing cardiovascular complications. Improved control of hyperglycemia or blood pressure reduces the risk of diabetic complications Administration of bexagliflozin, a potent SGLT2 inhibitor, has been shown to be well tolerated and to decrease HbA1c in subjects with type 2 diabetes. Study ...
Multiple Daily Injections and Continuous Glucose Monitoring in Diabetes: DIaMonD Study
The purpose of this study is to examine the potential value of adding CGM and possibly an insulin pump for persons with diabetes who use multiple daily insulin injections (MDI) and who rely on finger sticks alone to manage their blood sugar values. This study will also look at potential ...
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of LX-4211 as Adjunct Therapy in Adult Patients with Type 1 Diabetes Mellitus Who Have Inadequate Glycemic Control
Evaluate LX4211 in type 1 patients with poorly controlled blood sugars.
Diabetes Research Study
If you are at least 18 years of age and have been taking insulin for at least 6 months, you may qualify to participate in the clinical research study of an investigational anti-diabetes medication to evaluate its effect on blood sugar levels.
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Clinical Trial to Evaluate the Safety and Efficacy of Ertugliflozin (MK 8835/PF 04971729) in the Treatment of Subjects with Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and Sitagliptin.
The purpose of this study is to test the safety of ertugliflozin and see what effects (good and bad) that it has on adults with Type 2 diabetes whose blood sugar is not well controlled while being treated with metformin and sitagliptin (Januvia).
